In this webinar, Adrian Benjamin PhD, and Kimberly Robasky PhD detail how NGS technology can accelerate biomarker identification and bring down costs for research subject screening and safety monitoring – potentially making new treatments more effective. Among those technologies is RNA-Seq. Adrian and Kimberley summarize the clinical relevance of RNA-Seq, when and how to use expression profiling correctly, some common challenges and associated remedies. Webinar at a glance - Learn how legacy RNA-Seq datasets can be revisited for new insights to keep pace with today’s rapid advance of therapeutic breakthroughs - Learn how RNA-Seq provides high-throughput, comprehensive, direct measurement of functionally relevant molecular processes - Learn more about key applications for RNA-Seq in immuno-oncology Presenters: Adrian Benjamin, PhD Commercial Development Manager, Illumina Kimberley Robasky, PhD Associate Director, Lead Scientist, Bioinformatics and Clinical Systems Product Manager Q2 Solutions View related webinars RNA-Seq Techniques in Action http://mkt.illumina.com/CPBU-RNA-SeqWorkflows-Webinar-Landingpage-BoReese-Q32015.html?cstat=Attended%20On-demand View related videos Propelling Progress with RNA-Seq https://www.youtube.com/watch?v=qWd0N-Xj9y0 View related information Introduction to RNA Sequencing http://www.illumina.com/techniques/sequencing/rna-sequencing.html Subscribe to the Illumina video channel http://www.youtube.com/subscription_center?add_user=IlluminaInc